Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway

BACKGROUND: New acute and preventive migraine medications are available, but data on current treatment patterns are limited. This study describes migraine treatment patterns among patients initiating novel acute migraine specific medications (nAMSMs), overall and by prior use of anti-calcitonin gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zifan, Urman, Robert, Gill, Karminder, Park, Andrew S., Vuvu, Fiston, Patel, Leah B., Lu, Jingsong, Wade, Rolin L., Frerichs, Lindsay, Bensink, Mark E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634163/
https://www.ncbi.nlm.nih.gov/pubmed/37946113
http://dx.doi.org/10.1186/s10194-023-01678-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634163/
https://www.ncbi.nlm.nih.gov/pubmed/37946113
http://dx.doi.org/10.1186/s10194-023-01678-y

Ejemplares similares